189 related articles for article (PubMed ID: 28830241)
1. Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities.
Lunsky Y; Khuu W; Tadrous M; Vigod S; Cobigo V; Gomes T
Can J Psychiatry; 2018 Jun; 63(6):361-369. PubMed ID: 28830241
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic initiation among adults with intellectual and developmental disabilities in Ontario: a population-based cohort study.
Gomes T; Khuu W; Tadrous M; Vigod S; Cobigo V; Lunsky Y
BMJ Open; 2019 Jul; 9(7):e028125. PubMed ID: 31366646
[TBL] [Abstract][Full Text] [Related]
3. Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study.
Lin E; Balogh R; McGarry C; Selick A; Dobranowski K; Wilton AS; Lunsky Y
BMJ Open; 2016 Sep; 6(9):e011638. PubMed ID: 27591020
[TBL] [Abstract][Full Text] [Related]
4. Perinatal Health of Women with Intellectual and Developmental Disabilities and Comorbid Mental Illness.
Brown HK; Cobigo V; Lunsky Y; Dennis CL; Vigod S
Can J Psychiatry; 2016 Nov; 61(11):714-723. PubMed ID: 27310242
[TBL] [Abstract][Full Text] [Related]
5. How HIV affects health and service use for adults with intellectual and developmental disabilities.
Durbin A; Brown HK; Bansal S; Antoniou T; Jung JKH; Lunsky Y
J Intellect Disabil Res; 2017 Jul; 61(7):682-696. PubMed ID: 28612475
[TBL] [Abstract][Full Text] [Related]
6. Disparities in the Use of Guideline-Based Pharmacotherapy Exist for Atherosclerotic Cardiovascular Disease and Heart Failure Patients Who Have Intellectual/Developmental Disabilities in a Commercially Insured Database.
Erickson SR; Basu T; Dorsch MP; Kamdar N
Ann Pharmacother; 2020 Oct; 54(10):958-966. PubMed ID: 32336108
[TBL] [Abstract][Full Text] [Related]
7. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services.
Paton C; Flynn A; Shingleton-Smith A; McIntyre S; Bhaumik S; Rasmussen J; Hardy S; Barnes T
J Intellect Disabil Res; 2011 Jul; 55(7):665-74. PubMed ID: 21507097
[TBL] [Abstract][Full Text] [Related]
8. All-Cause, 30-Day Readmissions Among Persons With Intellectual and Developmental Disabilities and Mental Illness.
Balogh R; Lin E; Dobranowski K; Selick A; Wilton AS; Lunsky Y
Psychiatr Serv; 2018 Mar; 69(3):353-357. PubMed ID: 29137556
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of intellectual and developmental disabilities among first generation adult newcomers, and the health and health service use of this group: A retrospective cohort study.
Durbin A; Jung JKH; Chung H; Lin E; Balogh R; Lunsky Y
PLoS One; 2019; 14(6):e0215804. PubMed ID: 31220086
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and patterns of antipsychotic use and their associations with mental health and problem behaviours among older adults with intellectual disabilities.
O'Dwyer C; McCallion P; Henman M; McCarron M; O'Leary E; Burke E; O'Connell J; O'Dwyer M
J Appl Res Intellect Disabil; 2019 Jul; 32(4):981-993. PubMed ID: 31038275
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic medication prescription patterns in adults with developmental disabilities who have experienced psychiatric crisis.
Lunsky Y; Elserafi J
Res Dev Disabil; 2012; 33(1):32-8. PubMed ID: 22093645
[TBL] [Abstract][Full Text] [Related]
14. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
Aman MG; Gharabawi GM;
J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
[TBL] [Abstract][Full Text] [Related]
15. Repeat Emergency Department Visits for Individuals With Intellectual and Developmental Disabilities and Psychiatric Disorders.
Durbin A; Balogh R; Lin E; Wilton AS; Selick A; Dobranowski KM; Lunsky Y
Am J Intellect Dev Disabil; 2019 May; 124(3):206-219. PubMed ID: 31026200
[TBL] [Abstract][Full Text] [Related]
16. Assessing the utility of atypical antipsychotic medication in adults with mild mental retardation and comorbid psychiatric disorders.
Shedlack KJ; Hennen J; Magee C; Cheron DM
J Clin Psychiatry; 2005 Jan; 66(1):52-62. PubMed ID: 15669889
[TBL] [Abstract][Full Text] [Related]
17. Safety of antipsychotics in people with intellectual disability.
Frighi V; Stephenson MT; Morovat A; Jolley IE; Trivella M; Dudley CA; Anand E; White SJ; Hammond CV; Hockney RA; Barrow B; Shakir R; Goodwin GM
Br J Psychiatry; 2011 Oct; 199(4):289-95. PubMed ID: 21816867
[TBL] [Abstract][Full Text] [Related]
18. High health care costs among adults with intellectual and developmental disabilities: a population-based study.
Lunsky Y; De Oliveira C; Wilton A; Wodchis W
J Intellect Disabil Res; 2019 Feb; 63(2):124-137. PubMed ID: 30381849
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
[TBL] [Abstract][Full Text] [Related]
20. Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series.
Stogios N; Hahn MK; Lunsky Y; Desarkar P; Agarwal SM
J Clin Psychopharmacol; 2023 Jan-Feb 01; 43(1):60-63. PubMed ID: 36394921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
